These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35754202)

  • 1. Harmonizing platelet function analyzer testing and reporting in a large laboratory network.
    Favaloro EJ; Mohammed S; Vong R; Chapman K; Kershaw G; Just S; Connelly L; Ryan M; Zebeljan D; Brighton T; Pasalic L
    Int J Lab Hematol; 2022 Oct; 44(5):934-944. PubMed ID: 35754202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards 50 years of platelet function analyser (PFA) testing.
    Favaloro EJ; Pasalic L; Lippi G
    Clin Chem Lab Med; 2023 Apr; 61(5):851-860. PubMed ID: 35859143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA-200).
    Geevar T; Dave RG; Mathews NS; Kumar S; Mammen JJ; Vijayan R; Aboobacker FN; Abraham A; Srivastava A; Nair SC
    Int J Lab Hematol; 2022 Jun; 44(3):603-609. PubMed ID: 34986515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.
    Favaloro EJ; Kershaw G; Bukuya M; Hertzberg M; Koutts J
    Haemophilia; 2001 Mar; 7(2):180-9. PubMed ID: 11260278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
    Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
    Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
    Scavone M; Germanovich K; Femia EA; Cattaneo M
    Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia.
    Naik S; Teruya J; Dietrich JE; Jariwala P; Soundar E; Venkateswaran L
    Pediatr Blood Cancer; 2013 Jul; 60(7):1184-7. PubMed ID: 23335259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of the Anysis-200 platelet function analyzer in cardiac patients.
    Park SJ; Yoon J; Seo HS; Lim CS
    Clin Hemorheol Microcirc; 2022; 80(1):17-24. PubMed ID: 32116240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction.
    Harrison P; Robinson M; Liesner R; Khair K; Cohen H; Mackie I; Machin S
    Clin Lab Haematol; 2002 Aug; 24(4):225-32. PubMed ID: 12181026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.
    Favaloro EJ
    Thromb Res; 2020 Apr; 188():17-24. PubMed ID: 32036157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease.
    Buyukasik Y; Karakus S; Goker H; Haznedaroglu IC; Ozatli D; Sayinalp N; Ozcebe OI; Dundar SV; Kirazli S
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):349-53. PubMed ID: 12032401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems.
    Cariappa R; Wilhite TR; Parvin CA; Luchtman-Jones L
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):474-9. PubMed ID: 12794526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.